Based in Oklahoma City, an investment firm previously in the energy and oil space, and in the last year has expanded their interests to begin investing in the life science space as well. The firm is looking for new investment opportunities in the therapeutics, medical devices, diagnostics, and digital health sectors. The firm invests in Seed, Series A and B and is willing to both lead or participate in the investments. The firm is opportunistic in terms of sub-sectors and indications including all phases of development for therapeutics. Since starting to invest in the biotech space last fall, the firm currently has made 5 investments. The typical check size ranges from $500K up to $6M depending on the company and syndicate. The firm focuses on companies located in the United States.
The firm is looking for new investment opportunities in the therapeutics, medical devices, diagnostics, and digital health sectors. The firm is opportunistic in terms of sub-sectors and indications, including 510K and PMA classes of medical devices, as well as all phases of development for therapeutics including pre-clinical companies. The firm is also open to looking at pre-prototype companies on a case by case basis
The firm looks for a management team with a proven track record and strong sector knowledge and experience. The firm looks for companies who have done regulatory submission and successful exits as well. The firm is open to both leading or coinvesting in the investment and seeks board seat representation when leading an investment.
If you are interested in more information about this investor and other investors tracked by LSN, please email RESI@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment